PATENT CLAIM ANALYSIS

Application Number: 15756828
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["514", "04400A"]

Abstract:
The invention relates to the field of molecular biology and medicine, more specifically the invention is directed towards the treatment, delay and amelioration of heart diseases. More in particular, microRNAs are provided that induce cardiac regeneration by inducing cell cycle proliferation of cardiomyocytes, thereby treating or ameliorating heart diseases associated with a loss of cardiomyocytes or cardiomyocyte function. Such diseases include myocardial infarction, cardiomyopathy of ischemic or non-ischemic origin, myocarditis and heart failure. More in particular, the invention relates to a composition comprising a microRNA selected from the group consisting of microRNA 106b, microRNA 93 or microRNA 25 and the complements thereof, for use in the treatment, prevention, delay or amelioration of a heart disease.

Claim (Index 11):
The method according to  claim 2 , wherein the treatment improves cardiac function.

Metadata:
- Claim Count in Document: 18.0
- Percentile: 90.0
- Lexical Diversity: 1.73333
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14368149', '14766505', '15311765', '12737213', '14052538']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8094091510029741
- 35 USC 102 Novelty (BERT): 0.5551917168327317
- Combined Prediction Score: 0.7839874075859498
- Mean Citation Score: 374.361572
- Max Citation Score: 496.74808
- Similarity Product: 273.80438959953784

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test